EZH2 Expression Is Associated With High Proliferation Rate and Aggressive Tumor Subgroups in Cutaneous Melanoma and Cancers of the Endometrium, Prostate, and Breast
Top Cited Papers
- 10 January 2006
- journal article
- abstracts
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (2) , 268-273
- https://doi.org/10.1200/jco.2005.01.5180
Abstract
Purpose EZH2 is a member of the polycomb group of genes and important in cell cycle regulation. Increased expression of EZH2 has been associated previously with invasive growth and aggressive clini...Keywords
This publication has 18 references indexed in Scilit:
- A Basal Epithelial Phenotype Is More Frequent in Interval Breast Cancers Compared with Screen Detected TumorsCancer Epidemiology, Biomarkers & Prevention, 2005
- Activated p53 suppresses the histone methyltransferase EZH2 geneOncogene, 2004
- Prognostic Impact of Alterations in P-Cadherin Expression and Related Cell Adhesion Markers in Endometrial CancerJournal of Clinical Oncology, 2004
- Poorly Differentiated Breast Carcinoma is Associated with Increased Expression of the Human Polycomb Group EZH2 GeneNeoplasia, 2003
- EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancerThe EMBO Journal, 2003
- EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cellsProceedings of the National Academy of Sciences, 2003
- The polycomb group protein EZH2 is involved in progression of prostate cancerNature, 2002
- Programming off and on states in chromatin: mechanisms of Polycomb and trithorax group complexesCurrent Opinion in Genetics & Development, 2002
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991